研究者
J-GLOBAL ID：202101001790735293
更新日: 2023年08月12日
瓜生 英樹
うりゅう ひでき | Uryu Hideki
所属機関・部署：
職名：
助教
論文 (10件)：
-
Hideki Uryu, Takashi Nakamura, Daisuke Nakashima, Kazuyoshi Yamamoto, Yu Honda, Masahiro Ishikawa, Tomohiro Tsujita, Norihiko Hata, Toshinori Oinuma, Hiroyuki Yamazaki, et al. Miliary tuberculosis-associated hemophagocytic lymphohistiocytosis with a high level of soluble interleukin-2 receptor successfully treated with concomitant recombinant thrombomodulin: A case report. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023. 29. 3. 361-366
-
Hideki Uryu, Yuko Mishima, Naoko Tsuyama, Masahiro Yokoyama, Noriko Nishimura, Takanori Fukuta, Yuko Shirouchi, Takashi Okabe, Norihito Inoue, Kengo Takeuchi, et al. Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma. Leukemia & lymphoma. 2021. 62. 9. 2141-2150
-
Yuko Shirouchi, Masahiro Yokoyama, Takanori Fukuta, Hideki Uryu, Noriko Nishimura, Yuko Mishima, Norihito Inoue, Naoko Tsuyama, Kengo Takeuchi, Yasuhito Terui. Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population. Leukemia & lymphoma. 2021. 62. 8. 1869-1876
-
Yuko Mishima, Yuji Mishima, Yuko Shirouchi, Noriko Nishimura, Masahiro Yokoyama, Takashi Okabe, Norihito Inoue, Hideki Uryu, Takanori Fukuta, Kiyohiko Hatake, et al. The clonal evolution during long-term clinical course of multiple myeloma. International journal of hematology. 2021. 113. 2. 279-284
-
Takanori Fukuta, Noriko Nishimura, Yuko Shirouchi, Norihito Inoue, Hideki Uryu, Yoshiharu Kusano, Yuko Mishima, Masahiro Yokoyama, Naoko Tsuyama, Kengo Takeuchi, et al. Insignificance of surveillance imaging in patients with diffuse large B-cell lymphoma who achieved first complete remission: a retrospective cohort study. International journal of hematology. 2020. 111. 4. 567-573
もっと見る
MISC (3件)：
-
西脇 嘉一, 香取 美津治, 瓜生 英樹, 平野 慧, 細羽 梨花, 郡司 匡弘, 鈴木 一史, 増岡 秀一, 矢野 真吾. 当院における慢性特発性血小板減少性紫斑病に対するリツキシマブ療法の治療経験(Efficacy of rituximab in chronic immune thrombocytopenia: a retrospective survey at Kashiwa Hospital). 臨床血液. 2018. 59. 9. 1580-1580
-
横山 洋紀, 齋藤 健, 島田 貴, 南 次郎, 勝部 敦史, 神山 祐太郎, 鈴木 一史, 福島 僚子, 石井 敬人, 石井 彰子, et al. Clonal evolutionは急性骨髄性白血病の同種移植後の予後に影響する(Clonal evolution predicts the post-transplantation outcome in acute myeloid leukemia). 臨床血液. 2018. 59. 9. 1616-1616
-
鈴木 一史, 西脇 嘉一, 香取 美津治, 郡司 匡弘, 瓜生 英樹, 増岡 秀一, 矢野 真吾. レナリドミドを含む救援化学療法中にみられる好酸球増多は次治療までの期間延長の予後因子. International Journal of Myeloma. 2018. 8. 2. 139-139
講演・口頭発表等 (5件)：
-
Accompanying with additional complex karyotype is a poor prognostic factor in patients with multiple myeloma with high-risk cytogenetics in the era of novel agents
(18th International Myeloma Workshop 2021)
-
形質転換性濾胞性リンパ腫とリツキシマブ維持療法及び8番染色体異常の関連
(第82回日本血液学会学術集会 2020)
-
Cell-free DNA genotyping analysis in diffuse large B-cell lymphoma; the correlation between TP53 gene mutation and cereblon gene mutation
(61st American Society of Hematology Annual Meeting 2019)
-
形質転換を伴ったびまん性大細胞型B細胞リンパ腫と新規びまん性大細胞型B細胞リンパ腫の予後比較
(第81回日本血液学会学術集会 2019)
-
Efficacy of Rituximab Maintenance for Diffuse large B cell lymphoma with transformation
(60th American Society of Hematology Annual Meeting 2018)
学歴 (1件)：
学位 (1件)：
受賞 (1件)：
- 2022/03 - 第16回 日本血液学会関東甲信越地方会 優秀演題 骨髄生検を契機に診断された血球貪食性リンパ組織球症合併粟粒結核
前のページに戻る
